{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:38:16Z","timestamp":1787611096829,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.jconrel.2013.12.009","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T05:14:26Z","timestamp":1387430066000},"page":"79-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Characterization and evaluation of a modified PVPA barrier in comparison to Caco-2 cell monolayers for combined dissolution and permeation testing"],"prefix":"10.1016","volume":"175","author":[{"given":"Sandra P.","family":"Gantzsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birthe","family":"Kann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Ofer-Glaessgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Loos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1815-7730","authenticated-orcid":false,"given":"Harald","family":"Berchtold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Balbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2212-9521","authenticated-orcid":false,"given":"Thomas","family":"Eichinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5864-8462","authenticated-orcid":false,"given":"Claus-Michael","family":"Lehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich F.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Windbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2013.12.009_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/ps010203","article-title":"Prediction of dissolution\u2013absorption relationships from a continuous dissolution\/caco-2 system","volume":"1","author":"Ginski","year":"1999","journal-title":"AAPS PharmSci."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0010","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1023\/A:1026107906191","article-title":"In vitro system to evaluate oral absorption of poorly water-soluble drugs: simultaneous analysis on dissolution and permeation of drugs","volume":"20","author":"Kataoka","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(01)00663-9","article-title":"Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract","volume":"221","author":"Kobayashi","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.aca.2006.07.080","article-title":"Automated measurement of permeation and dissolution of propranolol HCl tablets using sequential injection analysis","volume":"581","author":"Motz","year":"2007","journal-title":"Anal. Chim. Acta."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0025","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0168-3659(99)00239-4","article-title":"Virtual screening of intestinal drug permeability","volume":"65","author":"Stenberg","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.12.009_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10565-005-0085-6","article-title":"The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics","volume":"21","author":"Sambuy","year":"2005","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijpharm.2010.03.046","article-title":"Online monitoring of transepithelial electrical resistance (TEER) in an apparatus for combined dissolution and permeation testing","volume":"392","author":"Muendoerfer","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0040","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1021\/jm970530e","article-title":"Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes","volume":"41","author":"Kansy","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0045","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/17425255.1.2.325","article-title":"The rise of PAMPA","volume":"1","author":"Avdeef","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0050","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2174\/138920008786485227","article-title":"Artificial membrane assays to assess permeability","volume":"9","author":"Faller","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejps.2011.12.007","article-title":"In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives","volume":"45","author":"Buckley","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejps.2005.08.007","article-title":"Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion","volume":"27","author":"Flaten","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0065","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ejps.2006.03.008","article-title":"Drug permeability across a phospholipid vesicle-based barrier-2. Characterization of barrier structure, storage stability and stability towards pH changes","volume":"28","author":"Flaten","year":"2006","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0070","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/jps.21894","article-title":"Investigating the relationship between drug distribution in solid lipid matrices and dissolution behaviour using Raman spectroscopy and mapping","volume":"99","author":"Windbergs","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0075","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1002\/jps.22609","article-title":"Analysis of matrix dosage forms during dissolution testing using Raman microscopy","volume":"100","author":"Haaser","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jconrel.2007.11.015","article-title":"Chemical imaging of drug eluting coatings: combining surface analysis and confocal Raman microscopy","volume":"126","author":"Belu","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.12.009_bb0085","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ejpb.2006.10.015","article-title":"Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell","volume":"66","author":"Motz","year":"2007","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0090","doi-asserted-by":"crossref","first-page":"061210","DOI":"10.1117\/1.JBO.18.6.061210","article-title":"Advanced chemical imaging and comparison of human and porcine hair follicles for drug delivery by confocal Raman microscopy","volume":"18","author":"Franzen","year":"2013","journal-title":"J. Biomed. Opt."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0095","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1208\/s12248-013-9457-7","article-title":"Chemical imaging of drug delivery systems with structured surfaces\u2014a combined analytical approach of confocal Raman microscopy and optical profilometry","volume":"15","author":"Kann","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0115","series-title":"PubChem Compound Database","author":"National Center for Biotechnology Information","year":"2013"},{"key":"10.1016\/j.jconrel.2013.12.009_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11095-004-9004-4","article-title":"Predicting drug disposition via application of BCS: transport\/absorption\/elimination interplay and development of a biopharmaceutics drug disposition classification system","volume":"22","author":"Wu","year":"2005","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0125","first-page":"281","article-title":"Solid state characterization of multicomponent inclusion complex of domperidone with \u03b2-cyclodextrin, polyvinyl pyrrolidone and citric acid","volume":"3","author":"Chavan","year":"2011","journal-title":"Der Pharmacia Lettre"},{"key":"10.1016\/j.jconrel.2013.12.009_bb0130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1021\/mp900191s","article-title":"Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP Levels, and role of time and site of access","volume":"7","author":"Collnot","year":"2010","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1021\/jm010152k","article-title":"Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates","volume":"45","author":"Mandagere","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0105","first-page":"64","article-title":"Mathematical comparison of dissolution profiles","volume":"20","author":"Moore","year":"1996","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.jconrel.2013.12.009_bb0110","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/j.2042-7158.2010.01172.x","article-title":"In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier","volume":"62","author":"Kanzer","year":"2010","journal-title":"J. Pharm. Pharmacol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913009516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913009516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T20:26:10Z","timestamp":1538943970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913009516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":26,"alternative-id":["S0168365913009516"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.12.009","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization and evaluation of a modified PVPA barrier in comparison to Caco-2 cell monolayers for combined dissolution and permeation testing","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}